Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Jan. 02, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Outlook Therapeutics, Inc....
-
Outlook Therapeutics, Inc. (OTLK) Misled Investors About the Viability and Efficacy of its Lead Product Candidate
-
Outlook Therapeutics, Inc. (OTLK) Misled Investors About the Viability and Efficacy of its Lead Product Candidate
-
Kaplan Fox reminds investors that a complaint has been filed on behalf of investors that purchased or otherwise acquired Outlook Therapeutics.
-
Outlook Therapeutics, Inc. (OTLK) Misled Investors About the Viability and Efficacy of its Lead Product Candidate
-
Outlook Therapeutics, Inc. (OTLK) Misled Investors About the Viability and Efficacy of its Lead Product Candidate
-
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Oct. 17, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Outlook Therapeutics, Inc....
-
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Oct. 11, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Outlook Therapeutics, Inc....